Federated Hermes
JANX icon

Federated Hermes’s Janux Therapeutics JANX Stock Holding History

Federated Hermes’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1M Buy
2,352,927
+2,298,727
+4,241% +$33.3M 0.05% 341
2026
Q1 		$753K Buy
54,200
+42,302
+356% +$580K ﹤0.01% 1195
2025
Q4 		$164K Buy
+11,898
New +$280K ﹤0.01% 1520

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Federated Hermes's JANX Position: Q2 2026 in Review

Federated Hermes increased its Janux Therapeutics (JANX) stake by 4,241% in Q2 2026, buying an estimated $33.3M and bringing the position to 2,352,927 shares worth $36.1M. The position accounts for 0.05% of the portfolio, ranked #341.

Federated Hermes first reported a position in JANX in Q4 2025 and has held it in 3 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Federated Hermes held 2,352,927 shares of Janux Therapeutics worth $36.1M as of Q2 2026.
  • Federated Hermes bought 2,298,727 Janux Therapeutics shares in Q2 2026, an estimated $33.3M.
  • Janux Therapeutics made up 0.05% of Federated Hermes's portfolio in Q2 2026, its #341 holding.
  • Federated Hermes first reported a position in Janux Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.